Clinical Trial Update: A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults with Multifocal Motor Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating two dose regimens of ARGX-117 in adults with Multifocal Motor Neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Motor Neuropathy

Drugs mentioned

• ARGX-117

Snippet

Sponsor: argenx | Conditions: Multifocal Motor Neuropathy | Phase 2 | Status: COMPLETED